The anti-obesity drug market is getting crowded. Many healthcare companies are working on their own GLP-1 drugs in an effort to take market share, which could amount to billions of dollars in revenue.

If you’ve been scoping punters for the Minnesota Vikings in the upcoming draft, the best one might fly off the […] ...

Viking's GLP-1 drug, VK2735, is currently in the midst of multiple clinical trials. The company is evaluating whether it can be taken monthly for maintenance dosing. 10 stocks we like better than ...

In theory, Florida defensive tackle Caleb Banks makes a lot of sense as a Vikings target if he's on the board when it's time to make the 18th overall pick in next month's NFL draft. Jonathan Allen and ...

Senior wing Elle Evans capped off her Kansas career in style on Friday night by winning the College 3-Point Championship at Hinkle Fieldhouse in Indianapolis. Not only did Evans emerge victorious from ...

Our latest mock draft has the Vikings trading up in the first round to land Notre Dame running back Jeremiyah Love. Michael Caterina / Imagn Images Free agency usually clarifies a team’s plan for the ...

The Minnesota Vikings are heading into a pivotal 2026 season, especially head coach Kevin O’Connell. O’Connell is heading into year 5 with zero playoff wins to his name in his tenure with Minnesota.

The Minnesota Vikings may not execute as many trades as they have in the last half-decade with Kwesi Adofo-Mensah gone from the front office, but with nine draft picks in their holster, deals cannot ...

J.J. McCarthy could have more opportunities in the NFL. J.J. McCarthy’s offseason could take a big turn if recent rumors materialize. The former No. 10 pick will face strong competition in the 2026 ...

The Minnesota Vikings are having a three-way QB battle between J.J. McCarthy, Carson Wentz, and Kyler Murray. Moreover, at the very least, the Vikings are giving themselves options to avoid another ...

A maintenance study could shed light on the tolerability of VK2735's oral formulation in 2026, ahead of the Phase 3 trial's conclusion. Viking Therapeutics has two Phase 3 trials in process for the ...